Century Therapeutics, Inc.IPSCNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank50
3Y CAGR-17.9%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
-17.9%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20250.54+10.1%
20240.49-53.8%
20231.07+8.9%
20220.98-55.5%
20212.20+118.7%
2020-11.76+13.7%
2019-13.63-